Sp1 Expression Regulates Lung Tumor Progression

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2011 Dec 14

PMID 22158040

Citations 83

Authors

T-I Hsu

M-C Wang

S-Y Chen

Y-M Yeh

W-C Su

W-C Chang

J-J Hung

Affiliations

Soon will be listed here.

Abstract

The role of specificity protein 1 (Sp1) in controlling gene expression in lung tumor development and metastasis is not well understood. In this study, we showed that the Sp1 level was highly increased and required for lung tumor growth in transgenic mice bearing Kras-induced lung tumors under the control of doxycycline. Furthermore, the Sp1 level was highly upregulated in lung adenocarcinoma cells with low invasiveness and in patients with stage I lung cancer. We also demonstrated that Sp1 was downregulated in lung adenocarcinoma cells with high invasiveness and in patients with stage IV lung adenocarcinoma. Moreover, Sp1 inversely regulated migration, invasion and metastasis of lung adenocarcinoma cells in vivo. In addition, a decrease in the Sp1 level in highly invasive lung adenocarcinoma cells resulted from instability of the Sp1 protein. Furthermore, overexpression of Sp1 in highly invasive lung adenocarcinoma cells increased expression of E-cadherin, a suppressor of metastasis, and attenuated the translocation of β-catenin into the cellular nucleus that leads to tumor malignancy. Taken together, Sp1 level accumulated strongly in early stage and then declined in late stage, which is important for lung cancer cell proliferation and metastasis during tumorigenesis.

Citing Articles

Dissecting the functions and regulatory mechanisms of disulfidoptosis-related RPN1 in pan-cancer: modulation of immune microenvironment and cellular senescence.

Qin L, Liang T, Zhang H, Gong X, Wei M, Song X Front Immunol. 2025; 15:1512445.

PMID: 39749324 PMC: 11693735. DOI: 10.3389/fimmu.2024.1512445.

Mechanical loading-induced alveolar bone remodeling is suppressed in the diabetic state via the impairment of the specificity protein 1/vascular endothelial growth factor (SP1/VEGF) axis.

Hoshino R, Nakamura N, Yamauchi T, Aoki Y, Miyabe M, Sasajima S J Diabetes Investig. 2024; 16(1):72-82.

PMID: 39460577 PMC: 11693532. DOI: 10.1111/jdi.14338.

Rab3B Proteins: Cellular Functions, Regulatory Mechanisms, and Potential as a Cancer Therapy Target.

Xu J, Zhang H, Yang L Cell Biochem Biophys. 2024; 83(1):263-277.

PMID: 39320613 DOI: 10.1007/s12013-024-01549-6.

DriverMP enables improved identification of cancer driver genes.

Liu Y, Han J, Kong T, Xiao N, Mei Q, Liu J Gigascience. 2023; 12.

PMID: 38091511 PMC: 10716827. DOI: 10.1093/gigascience/giad106.

Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer.

Xu X, Wang X, Chen Q, Zheng A, Li D, Meng Z J Transl Med. 2023; 21(1):307.

PMID: 37147632 PMC: 10163764. DOI: 10.1186/s12967-023-04141-3.

References

Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R . Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999; 285(5435):1923-6. DOI: 10.1126/science.285.5435.1923. View

Remsing L, Bahadori H, Carbone G, McGuffie E, Catapano C, Rohr J . Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target. Biochemistry. 2003; 42(27):8313-24. DOI: 10.1021/bi034091z. View

DeFino M, Wacker J, Lyssand J, Wang E, Hague C . Differential regulation of GPR54 transcription by specificity protein-1 and partial estrogen response element in mouse pituitary cells. Biochem Biophys Res Commun. 2010; 393(4):603-8. PMC: 2849983. DOI: 10.1016/j.bbrc.2010.02.026. View

Su K, Roos M, Yang X, Han I, Paterson A, Kudlow J . An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem. 1999; 274(21):15194-202. DOI: 10.1074/jbc.274.21.15194. View

Kumar A, Butler A . Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors. Cancer Lett. 1999; 137(2):159-65. DOI: 10.1016/s0304-3835(98)00351-6. View

Rivard N . Phosphatidylinositol 3-kinase: a key regulator in adherens junction formation and function. Front Biosci (Landmark Ed). 2009; 14(2):510-22. DOI: 10.2741/3259. View

Black A, Black J, Azizkhan-Clifford J . Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001; 188(2):143-60. DOI: 10.1002/jcp.1111. View

Zheng Y, Ritzenthaler J, Sun X, Roman J, Han S . Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1. Cancer Res. 2009; 69(3):896-904. DOI: 10.1158/0008-5472.CAN-08-2677. View

Maor S, Mayer D, Yarden R, Lee A, Sarfstein R, Werner H . Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J Endocrinol. 2006; 191(3):605-12. DOI: 10.1677/joe.1.07016. View

10.

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

11.

Chang H, Liu L, Hung W . Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal. 2004; 16(6):675-9. DOI: 10.1016/j.cellsig.2003.11.001. View

12.

Leroy I, Laurent G, Quillet-Mary A . Mithramycin A activates Fas death pathway in leukemic cell lines. Apoptosis. 2005; 11(1):113-9. DOI: 10.1007/s10495-005-3089-z. View

13.

Mitchell D, Stafford L, Li D, Bar-Eli M, Liu M . Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene. 2006; 26(12):1739-47. DOI: 10.1038/sj.onc.1209963. View

14.

Fisher G, Wellen S, Klimstra D, Lenczowski J, Tichelaar J, Lizak M . Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 2001; 15(24):3249-62. PMC: 312852. DOI: 10.1101/gad.947701. View

15.

Lee Y, Oslund K, Thai P, Velichko S, Fujisawa T, Duong T . 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced MUC5AC expression: aryl hydrocarbon receptor-independent/EGFR/ERK/p38-dependent SP1-based transcription. Am J Respir Cell Mol Biol. 2010; 45(2):270-6. PMC: 3175556. DOI: 10.1165/rcmb.2010-0313OC. View

16.

Bremnes R, Veve R, Hirsch F, Franklin W . The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer. 2002; 36(2):115-24. DOI: 10.1016/s0169-5002(01)00471-8. View

17.

Nicolas M, Noe V, Jensen K, Ciudad C . Cloning and characterization of the 5'-flanking region of the human transcription factor Sp1 gene. J Biol Chem. 2001; 276(25):22126-32. DOI: 10.1074/jbc.M010740200. View

18.

Denlinger C, Ikonomidis J, Reed C, Spinale F . Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers. J Thorac Cardiovasc Surg. 2010; 140(3):505-13. DOI: 10.1016/j.jtcvs.2010.02.061. View

19.

Jiang Y, Wang L, Gong W, Wei D, Le X, Yao J . A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 2005; 21(8):755-64. DOI: 10.1007/s10585-005-1198-2. View

20.

Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A . E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991; 113(1):173-85. PMC: 2288921. DOI: 10.1083/jcb.113.1.173. View